COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE

• Main Authors: E. S. Mazur (Author), R. M. Rabinovich (Author), V. V. Mazur (Author), N. S. Kuznetsova (Author), E. A. Kudryashova (Author), S. V. Veselov (Author), V. V. Bobkov (Author), D. Yu. Platonov (Author)
• Formato: Livro
• Publicado em: Столичная издательская компания, 2017-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Aim. To compare the efficacy and safety of thrombolytic therapy with recombinant non-immunogenic staphylokinase and tenecteplase in ST elevation myocardial infarction (STEMI) in real clinical practice.Material and methods. 84 patients with onset of STEMI symptoms up to 12 hours ago were included int...